NCT03926585 is a clinical trial in Hypothyroidism, sponsored by Birte Nygaard.

Who is sponsoring NCT03926585?

NCT03926585 is sponsored by Birte Nygaard.

What condition does NCT03926585 study?

NCT03926585 studies Hypothyroidism.

Is NCT03926585 still recruiting?

NCT03926585 is currently completed. Last updated 25 May 2023.

Last reviewed 2023-05-25 · How we verify

NCT03926585

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Variations in the DIO2 and MCT10 Genes and Effect of Triiodothyronine Treatment

Completed Last updated 25 May 2023

What this trial tests

trial in Hypothyroidism in 82 participants. Completed in 1 August 2022.

Timeline

23 April 2019

Primary endpoint
1 August 2022

1 August 2022

Quick facts

Lead sponsor	Birte Nygaard
Status	Completed
Study type	OBSERVATIONAL
Enrollment	82
Start date	23 April 2019
Primary completion	1 August 2022
Estimated completion	1 August 2022
Sites	1 location across Denmark

Conditions studied

Hypothyroidism — all drugs for Hypothyroidism →

Sponsor

Birte Nygaard

Who can join

Adults 18 to 80, any sex, with Hypothyroidism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hypothesis: Variations in the deiodinase 2 gene and monocarboxylate transporter 10 gene is associated with improvement in quality of life after initiation of combination therapy with L-Thyroxine and Liothyronine in patients with persistent hypothyroid symptoms despite conventional L-thyroxine mono-therapy. Purpose: To re-test this hypothesis in patients with continued perceived effect of Liothyronine treatment at least one year after initiation in a patient population more representing of daily clinical practice. The study will help determine whether testing of specific gene variations might predict longtime effect of combination therapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hypothyroidism

Currently open trials in the same condition.

NCT07060118 — Gluten Free Diet in Hashimoto's Hypothyroidism · NA · recruiting
NCT06757712 — Periodization Resistance Training on Quality of Life in Females With Hypothyroidism · NA · recruiting
NCT06731764 — Novel Approaches to the Treatment of Hypothyroidism · Phase 2, PHASE3 · recruiting
NCT06826248 — Clinical Efficacy of Darqeen Capsule for the Management of Hypothyroidism Associated with Female Reproductive Hormonal I · EARLY_PHASE1 · active not recruiting
NCT07421869 — SNUH Immune Checkpoint Inhibitor-induced Hypothyroidism Recovery Trial · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03926585 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Birte Nygaard
Last refreshed: 25 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03926585.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing